PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FULC vs. BIOX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


FULCBIOX
YTD Return-50.81%-53.24%
1Y Return-20.57%-44.99%
3Y Return (Ann)-43.01%-24.70%
5Y Return (Ann)-16.16%2.13%
Sharpe Ratio-0.17-1.25
Sortino Ratio0.55-1.87
Omega Ratio1.090.76
Calmar Ratio-0.17-0.70
Martin Ratio-0.40-1.71
Ulcer Index38.62%24.37%
Daily Std Dev94.01%33.45%
Max Drawdown-92.70%-60.06%
Current Drawdown-89.28%-59.88%

Fundamentals


FULCBIOX
Market Cap$227.14M$403.23M
EPS-$0.34$0.05
Total Revenue (TTM)$80.87M$472.93M
Gross Profit (TTM)$79.48M$186.84M
EBITDA (TTM)-$3.95M$50.25M

Correlation

-0.50.00.51.00.1

The correlation between FULC and BIOX is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

FULC vs. BIOX - Performance Comparison

The year-to-date returns for both stocks are quite close, with FULC having a -50.81% return and BIOX slightly lower at -53.24%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-57.41%
-44.22%
FULC
BIOX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FULC vs. BIOX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulcrum Therapeutics, Inc. (FULC) and Bioceres Crop Solutions Corp. (BIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FULC
Sharpe ratio
The chart of Sharpe ratio for FULC, currently valued at -0.17, compared to the broader market-4.00-2.000.002.004.00-0.17
Sortino ratio
The chart of Sortino ratio for FULC, currently valued at 0.55, compared to the broader market-4.00-2.000.002.004.006.000.55
Omega ratio
The chart of Omega ratio for FULC, currently valued at 1.09, compared to the broader market0.501.001.502.001.09
Calmar ratio
The chart of Calmar ratio for FULC, currently valued at -0.17, compared to the broader market0.002.004.006.00-0.17
Martin ratio
The chart of Martin ratio for FULC, currently valued at -0.40, compared to the broader market0.0010.0020.0030.00-0.40
BIOX
Sharpe ratio
The chart of Sharpe ratio for BIOX, currently valued at -1.25, compared to the broader market-4.00-2.000.002.004.00-1.25
Sortino ratio
The chart of Sortino ratio for BIOX, currently valued at -1.87, compared to the broader market-4.00-2.000.002.004.006.00-1.87
Omega ratio
The chart of Omega ratio for BIOX, currently valued at 0.76, compared to the broader market0.501.001.502.000.76
Calmar ratio
The chart of Calmar ratio for BIOX, currently valued at -0.69, compared to the broader market0.002.004.006.00-0.70
Martin ratio
The chart of Martin ratio for BIOX, currently valued at -1.71, compared to the broader market0.0010.0020.0030.00-1.71

FULC vs. BIOX - Sharpe Ratio Comparison

The current FULC Sharpe Ratio is -0.17, which is higher than the BIOX Sharpe Ratio of -1.25. The chart below compares the historical Sharpe Ratios of FULC and BIOX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00JuneJulyAugustSeptemberOctoberNovember
-0.17
-1.25
FULC
BIOX

Dividends

FULC vs. BIOX - Dividend Comparison

Neither FULC nor BIOX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

FULC vs. BIOX - Drawdown Comparison

The maximum FULC drawdown since its inception was -92.70%, which is greater than BIOX's maximum drawdown of -60.06%. Use the drawdown chart below to compare losses from any high point for FULC and BIOX. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%JuneJulyAugustSeptemberOctoberNovember
-89.28%
-59.88%
FULC
BIOX

Volatility

FULC vs. BIOX - Volatility Comparison

Fulcrum Therapeutics, Inc. (FULC) and Bioceres Crop Solutions Corp. (BIOX) have volatilities of 11.90% and 12.08%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%JuneJulyAugustSeptemberOctoberNovember
11.90%
12.08%
FULC
BIOX

Financials

FULC vs. BIOX - Financials Comparison

This section allows you to compare key financial metrics between Fulcrum Therapeutics, Inc. and Bioceres Crop Solutions Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items